Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This is a long-term, open-label, extension of the OMC-SXB-7 trial. Participants from the
OMC-SXB-7 open-label trial may be entered without any requirement as to length of
participation in that trial.
Approximately 70 patients are expected to participate at up to 6 investigative centers
located in Canada. The trial will continue for up to 24 months or until marketing approval,
whichever occurs sooner.